Shares of Blueprint Medicines Co. ( NASDAQ:BPMC – Get Rating ) fell 5.9% during mid-day trading on Thursday following insider selling activity. The company traded as low as $56.44 and last traded at $56.48. 317,027 shares changed hands during mid-day trading, a decline of 45% from the average session volume of 581,232 shares. The stock had previously closed at $60.03. Specifically, insider Percy H. Carter sold 2,307 shares of the company's stock in a transaction that occurred on Monday, June 5th.

https://www.dailypolitical.com/2023/06/08/blueprint-medicines-nasdaqbpmc-stock-price-down-5-9-on-insider-selling.html

#dailypolitical